Impact of hyperglycemia and age on outcomes in patients with acute myeloid leukemia

Susan Storey, Diane Von Ah

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose/Objectives: To examine the prevalence and impact of hyperglycemia on health outcomes (number of neutropenic days, infection, and hospital length of stay) in patients hospitalized for acute myeloid leukemia (AML) receiving initial induction therapy. Design: Retrospective, descriptive study. Setting: A large urban hospital in Indianapolis, IN. Sample: 103 patients with AML and a subset of 41 patients aged 65 years or older. Methods: Demographics and medical information were extracted from electronic health records. Serum-fasting blood glucose was used to assess glycemic status. The association of hyperglycemia with the health outcomes was analyzed. A subset of patients aged 65 years or older was also analyzed. Main Research Variables: Hyperglycemia, age, and health outcomes in patients with AML. Findings: Forty patients experienced hyperglycemia during initial induction for AML. In the larger sample, no associations were noted between hyperglycemia and health outcomes. A significant relationship (p = 0.022) was noted between hyperglycemia and infection in patients aged 65 years or older. Patients aged 65 years or older had 5.6 times the risk of developing infection as those aged younger than 65 years. Although not statistically significant, patients aged 65 years or older with hyperglycemia had 2.5 more days of neutropenia and 1.5 days longer hospital length of stay. Conclusions: This study provides preliminary evidence that hyperglycemia is prevalent during initial induction for AML and may have harmful consequences, particularly for patients aged 65 years or older. More research is needed to determine clinically significant levels of hyperglycemia and their impact on health outcomes. Implications for Nursing: Oncology nurses can assess and proactively collaborate with members of the healthcare team to implement strategies to prevent or mitigate the harmful consequences of hyperglycemia.

Original languageEnglish (US)
Pages (from-to)595-601
Number of pages7
JournalOncology Nursing Forum
Volume43
Issue number5
DOIs
StatePublished - Sep 1 2016

Fingerprint

Acute Myeloid Leukemia
Hyperglycemia
Length of Stay
Health
Infection
Oncology Nursing
Patient Care Team
Electronic Health Records
Urban Hospitals
Neutropenia
Research
Blood Glucose
Fasting
Retrospective Studies
Nurses
Demography
Serum

Keywords

  • Acute myeloid leukemia
  • Health outcomes
  • Hospital length of stay
  • Hyperglycemia
  • Infection
  • Neutropenic days

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Impact of hyperglycemia and age on outcomes in patients with acute myeloid leukemia. / Storey, Susan; Von Ah, Diane.

In: Oncology Nursing Forum, Vol. 43, No. 5, 01.09.2016, p. 595-601.

Research output: Contribution to journalArticle

@article{cf88d59212c14a929dc1883f51e2909d,
title = "Impact of hyperglycemia and age on outcomes in patients with acute myeloid leukemia",
abstract = "Purpose/Objectives: To examine the prevalence and impact of hyperglycemia on health outcomes (number of neutropenic days, infection, and hospital length of stay) in patients hospitalized for acute myeloid leukemia (AML) receiving initial induction therapy. Design: Retrospective, descriptive study. Setting: A large urban hospital in Indianapolis, IN. Sample: 103 patients with AML and a subset of 41 patients aged 65 years or older. Methods: Demographics and medical information were extracted from electronic health records. Serum-fasting blood glucose was used to assess glycemic status. The association of hyperglycemia with the health outcomes was analyzed. A subset of patients aged 65 years or older was also analyzed. Main Research Variables: Hyperglycemia, age, and health outcomes in patients with AML. Findings: Forty patients experienced hyperglycemia during initial induction for AML. In the larger sample, no associations were noted between hyperglycemia and health outcomes. A significant relationship (p = 0.022) was noted between hyperglycemia and infection in patients aged 65 years or older. Patients aged 65 years or older had 5.6 times the risk of developing infection as those aged younger than 65 years. Although not statistically significant, patients aged 65 years or older with hyperglycemia had 2.5 more days of neutropenia and 1.5 days longer hospital length of stay. Conclusions: This study provides preliminary evidence that hyperglycemia is prevalent during initial induction for AML and may have harmful consequences, particularly for patients aged 65 years or older. More research is needed to determine clinically significant levels of hyperglycemia and their impact on health outcomes. Implications for Nursing: Oncology nurses can assess and proactively collaborate with members of the healthcare team to implement strategies to prevent or mitigate the harmful consequences of hyperglycemia.",
keywords = "Acute myeloid leukemia, Health outcomes, Hospital length of stay, Hyperglycemia, Infection, Neutropenic days",
author = "Susan Storey and {Von Ah}, Diane",
year = "2016",
month = "9",
day = "1",
doi = "10.1188/16.ONF.595-601",
language = "English (US)",
volume = "43",
pages = "595--601",
journal = "Oncology Nursing Forum",
issn = "1538-0688",
publisher = "Oncology Nursing Society",
number = "5",

}

TY - JOUR

T1 - Impact of hyperglycemia and age on outcomes in patients with acute myeloid leukemia

AU - Storey, Susan

AU - Von Ah, Diane

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Purpose/Objectives: To examine the prevalence and impact of hyperglycemia on health outcomes (number of neutropenic days, infection, and hospital length of stay) in patients hospitalized for acute myeloid leukemia (AML) receiving initial induction therapy. Design: Retrospective, descriptive study. Setting: A large urban hospital in Indianapolis, IN. Sample: 103 patients with AML and a subset of 41 patients aged 65 years or older. Methods: Demographics and medical information were extracted from electronic health records. Serum-fasting blood glucose was used to assess glycemic status. The association of hyperglycemia with the health outcomes was analyzed. A subset of patients aged 65 years or older was also analyzed. Main Research Variables: Hyperglycemia, age, and health outcomes in patients with AML. Findings: Forty patients experienced hyperglycemia during initial induction for AML. In the larger sample, no associations were noted between hyperglycemia and health outcomes. A significant relationship (p = 0.022) was noted between hyperglycemia and infection in patients aged 65 years or older. Patients aged 65 years or older had 5.6 times the risk of developing infection as those aged younger than 65 years. Although not statistically significant, patients aged 65 years or older with hyperglycemia had 2.5 more days of neutropenia and 1.5 days longer hospital length of stay. Conclusions: This study provides preliminary evidence that hyperglycemia is prevalent during initial induction for AML and may have harmful consequences, particularly for patients aged 65 years or older. More research is needed to determine clinically significant levels of hyperglycemia and their impact on health outcomes. Implications for Nursing: Oncology nurses can assess and proactively collaborate with members of the healthcare team to implement strategies to prevent or mitigate the harmful consequences of hyperglycemia.

AB - Purpose/Objectives: To examine the prevalence and impact of hyperglycemia on health outcomes (number of neutropenic days, infection, and hospital length of stay) in patients hospitalized for acute myeloid leukemia (AML) receiving initial induction therapy. Design: Retrospective, descriptive study. Setting: A large urban hospital in Indianapolis, IN. Sample: 103 patients with AML and a subset of 41 patients aged 65 years or older. Methods: Demographics and medical information were extracted from electronic health records. Serum-fasting blood glucose was used to assess glycemic status. The association of hyperglycemia with the health outcomes was analyzed. A subset of patients aged 65 years or older was also analyzed. Main Research Variables: Hyperglycemia, age, and health outcomes in patients with AML. Findings: Forty patients experienced hyperglycemia during initial induction for AML. In the larger sample, no associations were noted between hyperglycemia and health outcomes. A significant relationship (p = 0.022) was noted between hyperglycemia and infection in patients aged 65 years or older. Patients aged 65 years or older had 5.6 times the risk of developing infection as those aged younger than 65 years. Although not statistically significant, patients aged 65 years or older with hyperglycemia had 2.5 more days of neutropenia and 1.5 days longer hospital length of stay. Conclusions: This study provides preliminary evidence that hyperglycemia is prevalent during initial induction for AML and may have harmful consequences, particularly for patients aged 65 years or older. More research is needed to determine clinically significant levels of hyperglycemia and their impact on health outcomes. Implications for Nursing: Oncology nurses can assess and proactively collaborate with members of the healthcare team to implement strategies to prevent or mitigate the harmful consequences of hyperglycemia.

KW - Acute myeloid leukemia

KW - Health outcomes

KW - Hospital length of stay

KW - Hyperglycemia

KW - Infection

KW - Neutropenic days

UR - http://www.scopus.com/inward/record.url?scp=84983795655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983795655&partnerID=8YFLogxK

U2 - 10.1188/16.ONF.595-601

DO - 10.1188/16.ONF.595-601

M3 - Article

C2 - 27541552

AN - SCOPUS:84983795655

VL - 43

SP - 595

EP - 601

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 1538-0688

IS - 5

ER -